摘要
目的分析非小细胞肺癌内科治疗的依从性现状及对策。方法回顾性分析我院2013年5月~2015年5月行内科治疗的40例非小细胞癌肺癌患者临床资料,依据是否顺利完成内科6个疗程治疗分为依从性好组30例及依从性差组10例,分析影响依从性的原因并探索相应对策。结果两组患者TNM分期、毒副反应、负性心理、有无医保等方面相比较,差异有统计学意义（P〈0.05）;Logistic回归分析结果提示,毒副反应、负性心理为非小细胞肺癌内科治疗依从性的独立影响因素（OR：3.889、4.554,95%CI：1.568~5.334、1.789~5.880,P〈0.05）。结论医务人员做好良好的医患沟通工作,并结合患者实际情况制定针对性、个体化内科治疗方案将有助于提高治疗依从性。
Objective To analyze the status quo and countermeasure of compliance to medical treatment of non-small-cell lung cancer. Methods Clinical data of 40 patients with non-small-cell lung cancer treated by internal medicine in our hospital from May 2013 to May 2015 were analyzed retrospectively. They were divided into 30 cases of good compliance group and 10 cases of poor compliance group according to whether they had successfully completed 6 courses of medical treatment. The reasons that influence compliance and the corresponding countermeasures were discussed. Results There was statistically significant difference between two groups of patients with TNM stage,toxic,side effects,negative psychological and whether had health insurance or not（P〈0.05）. Logistic regression analysis showed that independent risk factors of treatment compliance for non-small cell lung cancer were toxicity and negative psychology（OR：3.889,4.554,95%CI ：1.568 ~ 5.334,1.789 ~ 5.880,P〈0.05）.Conclusion Medical staff need to do a good job on patients communication,and combine with the actual situation of patients to develop targeted,individualized medical treatment program to help improve the treatment compliance.
出处
《中国卫生标准管理》
2016年第21期53-55,共3页
China Health Standard Management
关键词
非小细胞肺癌
内科治疗
依从性
Non-small-cell lung cancer
Medical treatment
Compliance
